SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
Exact Name of Registrant as Specified in its Charter
| State of Incorporation | Commission File Number | IRS Employer Identification Number | ||||||
Address of principal executive offices, including zip code
(626 ) 293-3400
Registrant’s telephone number, including area code
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Securities registered pursuant to Section 12(b) of the Act:
Title of Each Class | Trading symbol(s) | Name of Each Exchange on Which Registered | ||||||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition.
On February 8, 2023, EMCORE Corporation (the “Registrant”) issued a press release disclosing its financial results for its first fiscal quarter ended December 31, 2022. A copy of this press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K (“Current Report”).
The information in this Current Report, including Exhibit 99.1 hereto, shall not be incorporated by reference into any filing of the Registrant under the Securities Act of 1933 or the Securities Exchange Act of 1934 (the “Exchange Act”), whether made before or after the date hereof, regardless of any general incorporation language in such filing, unless expressly incorporated by specific reference in such filing. Furthermore, the information in this Current Report, including Exhibit 99.1 hereto, shall not be deemed to be “filed” for purposes of Section 18 of the Exchange Act, or otherwise be subject to the liabilities of that section.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
| Exhibit Number | Exhibit Description | |||||||
| 99.1 | ||||||||
104 | Cover Page Interactive Data File (embedded within the Inline XBRL document). | |||||||
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| EMCORE CORPORATION | ||||||||
| By: | /s/ Tom Minichiello | |||||||
| Name: | Tom Minichiello | |||||||
| February 8, 2023 | Title: | Chief Financial Officer | ||||||
Exhibit 99.1
EMCORE Reports Fiscal 2023 First Quarter Results
ALHAMBRA, CA, February 8, 2023 – EMCORE Corporation (Nasdaq: EMKR), a leading provider of advanced mixed-signal products that serve the aerospace and defense, communications, and sensing markets, today announced results for the fiscal 2023 first quarter (1Q23) ended December 31, 2022. Management will host a conference call to discuss 1Q23 financial and business results today at 5:00 p.m. Eastern Time (ET).
For 1Q23, EMCORE’s consolidated revenue was $25.0 million, comprised of $21.7 million from the Aerospace and Defense (A&D) segment and $3.3 million from the Broadband segment. Net loss was $11.7 million and $8.2 million on a GAAP and non-GAAP basis, respectively. Adjusted EBITDA was negative $6.5 million. Please refer to the schedules at the end of this press release for GAAP to non-GAAP reconciliations and other information related to non-GAAP financial measures.
“We made solid progress toward turning EMCORE into a larger and profitable Inertial Navigation provider to the A&D market. In 1Q23, A&D accounted for 87% of the Company’s revenue and grew 3% sequentially despite delayed customer shipments for QMEMS. A&D book-to-bill was approximately 1.2, and segment gross margin rebounded to 22% with our navigation products performing better than that,” said Jeff Rittichier, President and Chief Executive Officer of EMCORE. “As we stated over the last couple of quarters, our recently acquired operations in Budd Lake, NJ and Tinley Park, IL make EMCORE the world’s largest independent1 Inertial Navigation business and our highest priorities are simplifying operations, driving growth, and improving cash flow. Consistent with these objectives, EMCORE is in discussions with several interested parties to divest our non-strategic product lines.”
Consolidated Results
| Three Months Ended | |||||||||||
| Dec 31, 2022 | Sep 30, 2022 | +increase/ -decrease | |||||||||
| 1Q23 | 4Q22 | ||||||||||
| Revenue | $25.0M | $25.6M | -$0.6M | ||||||||
| Gross margin | 12% | 4% | +8% | ||||||||
| Operating expenses | $14.6M | $18.2M | -$3.6M | ||||||||
| Operating margin | (46 %) | (67 %) | +21% | ||||||||
| Net loss | ($11.7M) | ($16.9M) | +$5.2M | ||||||||
| Net loss per share diluted | ($0.31) | ($0.45) | +$0.14 | ||||||||
| Non-GAAP gross margin (a) | 15% | 2% | +13% | ||||||||
| Non-GAAP operating expenses (a) | $11.8M | $11.2M | +$0.6M | ||||||||
| Non-GAAP operating margin (a) | (32%) | (42%) | +10% | ||||||||
| Non-GAAP net loss (a) | ($8.2M) | ($10.9M) | +$2.7M | ||||||||
| Non-GAAP net loss per share diluted (a) | ($0.22) | ($0.29) | +$0.07 | ||||||||
| Adjusted EBITDA | ($6.5M) | ($9.4M) | +$2.9M | ||||||||
| Ending cash and cash equivalents | $24.2M | $26.1M | -$1.9M | ||||||||
| Line of credit and loan payable | $12.3M | $15.5M | -$3.2M | ||||||||
| (a) Please refer to the schedules at the end of this press release for GAAP to non-GAAP reconciliations and other information related to non-GAAP financial measures. | |||||||||||
Aerospace and Defense Segment
For 1Q23, A&D’s sequential-quarter revenue increase was driven by solid performances across all product lines, with the exception of QMEMS which decreased due primarily to customer shipment delays. A&D segment gross margin rebounded due to the absence of items that were experienced in the prior quarter related to QMEMS inventory valuation charges and the transition of newly acquired operations in Budd Lake, NJ and Tinley Park, IL. R&D expenses increased sequentially due to a full quarter of results for the Tinley Park, which was acquired on August 9, 2022.
1 All sales are to unaffiliated third-party customers.
| Three Months Ended | |||||||||||
| Dec 31, 2022 | Sep 30, 2022 | +increase/ -decrease | |||||||||
| 1Q23 | 4Q22 | ||||||||||
| A&D segment revenue | $21.7M | $21.0M | +$0.7M | ||||||||
| A&D segment gross margin | 19% | 4% | +15% | ||||||||
| A&D segment R&D expense | $4.3M | $3.5M | +$0.8M | ||||||||
| A&D segment profit | ($0.2M) | ($2.6M) | +$2.4M | ||||||||
| Non-GAAP A&D segment gross margin (a) | 22% | 2% | +20% | ||||||||
| Non-GAAP A&D segment R&D expense (a) | $4.2M | $3.7M | +$0.5M | ||||||||
| Non-GAAP A&D segment profit (a) | $0.6M | ($3.3M) | +$3.9M | ||||||||
| (a) Please refer to the schedules at the end of this press release for GAAP to non-GAAP reconciliations and other information related to non-GAAP financial measures. | |||||||||||
Broadband Segment
For 1Q23, Broadband’s sequential-quarter revenue decrease was primarily due to lower sales of CATV products and Chips. Broadband segment gross margin declined as a result of the lower revenue and higher under-absorption of fixed overhead. R&D expenses decreased due primarily to the CATV and Sensing product lines.
| Three Months Ended | |||||||||||
| Dec 31, 2022 | Sep 30, 2022 | +increase/ -decrease | |||||||||
| 1Q23 | 4Q22 | ||||||||||
| Broadband segment revenue | $3.3M | $4.6M | -$1.3M | ||||||||
| Broadband segment gross margin | (32%) | 3% | -35% | ||||||||
| Broadband segment R&D expense | $1.0M | $1.4M | -$0.4M | ||||||||
| Broadband segment profit | ($2.1M) | ($1.2M) | -$0.9M | ||||||||
| Non-GAAP Broadband segment gross margin (a) | (27%) | 1% | -28% | ||||||||
| Non-GAAP Broadband segment R&D expense (a) | $0.9M | $1.6M | -$0.7M | ||||||||
| Non-GAAP Broadband segment profit (a) | ($1.8M) | ($1.5M) | -$0.3M | ||||||||
| (a) Please refer to the schedules at the end of this press release for GAAP to non-GAAP reconciliations and other information related to non-GAAP financial measures. | |||||||||||
Business Outlook
The Company expects revenue for 2Q23 ending March 31, 2023 to be in the range of $27 million to $29 million.
Conference Call
The Company will discuss its financial results on Wednesday, February 8, 2023 at 5:00 p.m. ET (2:00 p.m. PT). To participate in the conference call, click on the following link (ten minutes prior to the call) to register: https://register.vevent.com/register/BIab6db815060c490ea029519066ebcd1c. Once registered, participants will have the option of: 1) dialing in from their phone (using their PIN); or 2) clicking the “Call Me” option to receive an automated call directly to their phone. The call will be webcast live via the Company's website at https://investor.emcore.com. A webcast will be available for replay following the conclusion of the call.
About EMCORE
EMCORE Corporation is a leading provider of advanced mixed-signal products that serve the aerospace and defense, communications, and sensing markets. Our best-in-class components and systems support a broad array of applications including navigation and inertial sensing, defense optoelectronics, broadband communications, optical sensing, and specialty chips for telecom and data centers. We leverage industry-leading Photonic Integrated Chip (PIC), Quartz MEMS, Lithium Niobate, and Indium Phosphide chip-level technology to deliver state-of-the-art component and system-level products across our end-market applications. EMCORE has vertically-integrated manufacturing capability at its facilities in Alhambra, CA, Budd Lake, NJ, Concord, CA, and Tinley Park, IL. Our manufacturing facilities maintain ISO 9001 quality management
certification, and we are AS9100 aerospace quality certified at our facilities in Budd Lake and Concord. For further information about EMCORE, please visit http://www.emcore.com.
Use of Non-GAAP Financial Measures
The Company conforms to U.S. Generally Accepted Accounting Principles (“GAAP”) in the preparation of its financial statements. We disclose supplemental non-GAAP earnings measures for gross margin, operating expenses, research and development expenses, operating margin, and net loss, as well as adjusted EBITDA.
Management believes these supplemental non-GAAP measures reflect the Company’s core ongoing operating performance and facilitates comparisons across reporting periods. The Company uses these measures when evaluating its financial results and for planning and forecasting of future periods. We believe that these supplemental non-GAAP measures are also useful to investors in assessing our operating performance. While we believe in the usefulness of these supplemental non-GAAP measures, there are limitations. Our non-GAAP measures may not be reported by other companies in our industry and/or may not be directly comparable to similarly titled measures of other companies due to potential differences in calculation. We compensate for these limitations by using these non-GAAP measures as a supplement to GAAP and by providing the reconciliations to the most comparable GAAP measure.
The schedules at the end of this press release reconcile the Company’s non-GAAP measures to the most directly comparable GAAP measure. The adjustments share one or more of the following characteristics: they are unusual and the Company does not expect them to recur in the ordinary course of its business, they do not involve the expenditure of cash, they are unrelated to the ongoing operation of the business in the ordinary course, or their magnitude and timing is largely outside of the Company’s control. For all reporting periods disclosed, the Company has applied consistent rationale, method, and adjustments in reconciling non-GAAP measures to the most directly comparable GAAP measure.
Non-GAAP measures are not in accordance with or an alternative to GAAP, nor are they meant to be considered in isolation or as a substitute for comparable GAAP measures. Our disclosures of these measures should be read only in conjunction with our financial statements prepared in accordance with GAAP. Non-GAAP measures should not be viewed as a substitute for the Company’s GAAP results.
Forward-Looking Statements
The information provided herein may include forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 (“Exchange Act”). These forward-looking statements are largely based on our current expectations and projections about future events and financial trends affecting the financial condition of our business. Such forward-looking statements include, in particular, projections about our future results, including expected revenue for 2Q23, and statements about our future results of operations and financial position, plans, strategies, business prospects, changes, and trends in our business and the markets in which we operate.
These forward-looking statements may be identified by the use of terms and phrases such as “anticipates”, “believes”, “can”, “could”, “estimates”, “expects”, “forecasts”, “intends”, “may”, “plans”, “projects”, “targets”, “will”, and similar expressions or variations of these terms and similar phrases. Additionally, statements concerning future matters such as the development of new products, future growth, enhancements or technologies, sales levels, expense levels, and other statements regarding matters that are not historical are forward-looking statements. We caution that these forward-looking statements relate to future events or our future financial performance and are subject to business, economic, and other risks and uncertainties, both known and unknown, that may cause actual results, levels of activity, performance, or achievements of our business or our industry to be materially different from those expressed or implied by any forward-looking statements.
These forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those projected, including without limitation, the following: (a) uncertainties regarding the effects of the COVID-19 pandemic, the length of time it will take for the COVID-19 pandemic to subside, and the impact of measures intended to reduce its spread on our business and operations, which is evolving and beyond our control; (b) the rapidly evolving markets for the Company's products and uncertainty regarding the development of these markets; (c) the Company's and the acquired businesses historical dependence on sales to a limited number of customers and fluctuations in the mix of products and customers in any period; (d) delays and other difficulties in commercializing new products; (e) the failure of new products: (i) to perform as expected without material defects, (ii) to be manufactured at acceptable volumes, yields, and cost, (iii) to be qualified and accepted by our customers, and (iv) to successfully compete with products offered by our competitors; (f) uncertainties concerning the availability and cost of commodity materials and specialized product components that we do not make internally; (g) actions by
competitors; (h) risks and uncertainties related to applicable laws and regulations, including the impact of changes to applicable tax laws and tariff regulations; (i) acquisition-related risks, including that (i) the revenues and net operating results obtained from our recent acquisitions may not meet our expectations, (ii) the costs and cash expenditures for integration of our recent acquisitions may be higher than expected, (iii) we may not recognize the anticipated synergies from our recent acquisitions, (iv) there could be losses and liabilities arising from these acquisitions that we will not be able to recover from any source, and (v) we may not realize sufficient scale from these acquisitions and will need to take additional steps, including making additional acquisitions, to achieve our growth objectives for this product line; (j) risks related to our ability to obtain capital; (k) the effect of component shortages and any alternatives thereto; (l) risks and uncertainties related to manufacturing and production capacity and expansion plans related thereto; (m) risks related to the conversion of order backlog into product revenue; and (n) other risks and uncertainties discussed under Item 1A - Risk Factors in our Annual Report on Form 10-K for the fiscal year ended September 30, 2022, as updated by our subsequent periodic reports.
Forward-looking statements are based on certain assumptions and analysis made in light of our experience and perception of historical trends, current conditions, and expected future developments as well as other factors that we believe are appropriate under the circumstances. While these statements represent our judgment on what the future may hold, and we believe these judgments are reasonable, these statements are not guarantees of any events or financial results. All forward-looking statements in this press release are made as of the date hereof, based on information available to us as of the date hereof, and subsequent facts or circumstances may contradict, obviate, undermine, or otherwise fail to support or substantiate such statements. We caution you not to rely on these statements without also considering the risks and uncertainties associated with these statements and our business that are addressed in our filings with the Securities and Exchange Commission (“SEC”) that are available on the SEC’s web site located at www.sec.gov, including the sections entitled “Risk Factors” in our Annual Report on Form 10-K and our Quarterly Reports on Form 10-Q. Certain information included in this press release may supersede or supplement forward-looking statements in our other Exchange Act reports filed with the SEC. We do not intend to update any forward-looking statement to conform such statements to actual results or to changes in our expectations, except as required by applicable law or regulation.
EMCORE CORPORATION
Condensed Consolidated Balance Sheets
(unaudited)
| December 31, | September 30, | ||||||||||
| (in thousands) | 2022 | 2022 | |||||||||
| ASSETS | |||||||||||
| Current assets: | |||||||||||
| Cash and cash equivalents | $ | 23,692 | $ | 25,625 | |||||||
| Restricted cash | 495 | 520 | |||||||||
| Accounts receivable, net of credit loss of $361 and $337, respectively | 17,116 | 18,073 | |||||||||
| Contract assets | 5,570 | 6,846 | |||||||||
| Inventory | 39,598 | 37,035 | |||||||||
| Prepaid expenses | 3,374 | 4,061 | |||||||||
| Other current assets | 2,148 | 3,063 | |||||||||
| Total current assets | 91,993 | 95,223 | |||||||||
| Property, plant, and equipment, net | 27,660 | 37,867 | |||||||||
| Goodwill | 16,519 | 15,608 | |||||||||
| Operating lease right-of-use assets | 27,937 | 23,243 | |||||||||
| Other intangible assets, net | 15,234 | 14,790 | |||||||||
| Other non-current assets | 2,425 | 2,351 | |||||||||
| Total assets | $ | 181,768 | $ | 189,082 | |||||||
| LIABILITIES and SHAREHOLDERS’ EQUITY | |||||||||||
| Current liabilities: | |||||||||||
| Accounts payable | $ | 12,545 | $ | 12,729 | |||||||
| Accrued expenses and other current liabilities | 11,197 | 8,124 | |||||||||
| Contract liabilities | 4,125 | 5,300 | |||||||||
| Loan payable - current | 852 | 852 | |||||||||
| Operating lease liabilities - current | 2,530 | 2,213 | |||||||||
| Total current liabilities | 31,249 | 29,218 | |||||||||
| Line of credit | 6,638 | 9,599 | |||||||||
| Loan payable - non-current | 4,829 | 5,042 | |||||||||
| Operating lease liabilities - non-current | 26,121 | 21,625 | |||||||||
| Asset retirement obligations | 4,110 | 4,664 | |||||||||
| Other long-term liabilities | — | 106 | |||||||||
| Total liabilities | 72,947 | 70,254 | |||||||||
| Commitments and contingencies | |||||||||||
| Shareholders’ equity: | |||||||||||
| Common stock, no par value, 100,000 shares authorized; 44,774 shares issued and 37,868 shares outstanding as of December 31, 2022; 44,497 shares issued and 37,591 shares outstanding as of September 30, 2022 | 789,080 | 787,347 | |||||||||
| Treasury stock at cost; 6,906 shares as of December 31, 2022 and September 30, 2022 | (47,721) | (47,721) | |||||||||
| Accumulated other comprehensive income | 1,254 | 1,301 | |||||||||
| Accumulated deficit | (633,792) | (622,099) | |||||||||
| Total shareholders’ equity | 108,821 | 118,828 | |||||||||
| Total liabilities and shareholders’ equity | $ | 181,768 | $ | 189,082 | |||||||
EMCORE CORPORATION
Condensed Consolidated Statements of Operations and Comprehensive Loss
(unaudited)
| Three Months Ended December 31, | |||||||||||
| (in thousands, except for per share data) | 2022 | 2021 | |||||||||
| Revenue | $ | 24,953 | $ | 42,236 | |||||||
| Cost of revenue | 21,894 | 26,439 | |||||||||
| Gross profit | 3,059 | 15,797 | |||||||||
| Operating expense: | |||||||||||
| Selling, general, and administrative | 9,944 | 7,187 | |||||||||
| Research and development | 5,351 | 4,627 | |||||||||
| Severance | 475 | 1,298 | |||||||||
| (Gain) loss on sale of assets | (1,171) | 187 | |||||||||
| Total operating expense | 14,599 | 13,299 | |||||||||
| Operating (loss) income | (11,540) | 2,498 | |||||||||
| Other (expense) income: | |||||||||||
| Interest expense, net | (241) | (11) | |||||||||
| Foreign exchange gain | 75 | 42 | |||||||||
| Other income | 107 | — | |||||||||
| Total other (expense) income | (59) | 31 | |||||||||
| (Loss) income before income tax expense | (11,599) | 2,529 | |||||||||
| Income tax expense | (94) | (115) | |||||||||
| Net (loss) income | $ | (11,693) | $ | 2,414 | |||||||
| Foreign exchange translation adjustment | 47 | 20 | |||||||||
| Comprehensive (loss) income | $ | (11,646) | $ | 2,434 | |||||||
| Per share data | |||||||||||
| Net (loss) income per basic share | $ | (0.31) | $ | 0.07 | |||||||
| Weighted-average number of basic shares outstanding | 37,557 | 36,950 | |||||||||
| Net (loss) income per diluted share | $ | (0.31) | $ | 0.06 | |||||||
| Weighted-average number of diluted shares outstanding | 37,557 | 39,031 | |||||||||
EMCORE CORPORATION
Reconciliations of GAAP to Non-GAAP Financial Measures
(unaudited)
| Three Months Ended | |||||||||||
| Dec 31, 2022 | Sep 30, 2022 | ||||||||||
| (in thousands, except for percentages) | 1Q23 | 4Q22 | |||||||||
| Gross profit | $ | 3,059 | $ | 1,006 | |||||||
| Gross margin | 12% | 4% | |||||||||
| Stock-based compensation expense | 387 | 348 | |||||||||
| Asset retirement obligation accretion | 51 | 64 | |||||||||
| Amortization of intangible assets | 326 | 58 | |||||||||
| Variable compensation accrual adjustment | — | (1,040) | |||||||||
| Non-GAAP gross profit | $ | 3,823 | $ | 436 | |||||||
| Non-GAAP gross margin | 15% | 2% | |||||||||
| Three Months Ended | |||||||||||
| Dec 31, 2022 | Sep 30, 2022 | ||||||||||
| (in thousands) | 1Q23 | 4Q22 | |||||||||
Operating expense | $ | 14,599 | $ | 18,246 | |||||||
Stock-based compensation expense | (1,347) | (1,271) | |||||||||
Severance expense | (475) | (35) | |||||||||
CATV transition - gain on sale of assets | — | 767 | |||||||||
| Acquisition-related - gain on sale of assets | 1,171 | — | |||||||||
| Acquisition-related expense | (2,060) | (5,166) | |||||||||
| Litigation-related expense | (105) | (413) | |||||||||
| Variable compensation accrual adjustment | — | 2,030 | |||||||||
| Impairment charge | — | (2,956) | |||||||||
| Non-GAAP operating expense | $ | 11,783 | $ | 11,202 | |||||||
| Three Months Ended | |||||||||||
| Dec 31, 2022 | Sep 30, 2022 | ||||||||||
| (in thousands, except for percentages) | 1Q23 | 4Q22 | |||||||||
| Operating profit | $ | (11,540) | $ | (17,240) | |||||||
| Operating margin | (46%) | (67%) | |||||||||
| Stock-based compensation expense | 1,734 | 1,619 | |||||||||
| Asset retirement obligation accretion | 51 | 64 | |||||||||
| Amortization of acquired intangibles | 326 | 58 | |||||||||
| Severance expense | 475 | 35 | |||||||||
| CATV transition - gain on sale of assets | — | (766) | |||||||||
| Acquisition-related - gain on sale of assets | (1,171) | — | |||||||||
| Acquisition-related expense | 2,060 | 5,166 | |||||||||
| Litigation-related expense | 105 | 413 | |||||||||
| Variable compensation accrual adjustment | — | (3,070) | |||||||||
| Impairment charge | — | 2,956 | |||||||||
| Non-GAAP operating profit | $ | (7,960) | $ | (10,765) | |||||||
| Non-GAAP operating margin | (32%) | (42%) | |||||||||
| Depreciation expense | 1,450 | 1,381 | |||||||||
| Adjusted EBITDA | $ | (6,510) | $ | (9,384) | |||||||
| Adjusted EBITDA % | (26%) | (37%) | |||||||||
| Three Months Ended | |||||||||||
| Dec 31, 2022 | Sep 30, 2022 | ||||||||||
| (in thousands, except for per share data and percentages) | 1Q23 | 4Q22 | |||||||||
| Net loss | $ | (11,693) | $ | (16,873) | |||||||
| Net loss per share basic and diluted | $ | (0.31) | $ | (0.45) | |||||||
| Stock-based compensation expense | 1,734 | 1,619 | |||||||||
| Asset retirement obligation accretion | 51 | 64 | |||||||||
| Amortization of intangible assets | 326 | 58 | |||||||||
| Severance expense | 475 | 35 | |||||||||
| CATV transition - gain on sale of assets | — | (766) | |||||||||
| Acquisition-related - gain on sale of assets | (1,171) | — | |||||||||
| Acquisition-related expense | 2,060 | 5,166 | |||||||||
| Litigation-related expense | 105 | 413 | |||||||||
| Variable compensation accrual adjustment | — | (3,070) | |||||||||
| Impairment charge | — | 2,956 | |||||||||
| Other income | (107) | (520) | |||||||||
| Foreign exchange (gain) loss | (75) | 192 | |||||||||
| Income tax expense (benefit) | 94 | (164) | |||||||||
| Non-GAAP net loss | $ | (8,201) | $ | (10,890) | |||||||
| Non-GAAP net loss per share basic and diluted | $ | (0.22) | $ | (0.29) | |||||||
| Interest expense, net | 241 | 125 | |||||||||
| Depreciation expense | 1,450 | 1,381 | |||||||||
| Adjusted EBITDA | $ | (6,510) | $ | (9,384) | |||||||
| Adjusted EBITDA % | (26 | %) | (37 | %) | |||||||
| Three Months Ended | Three Months Ended | |||||||||||||||||||||||||
| (in thousands, except for percentages) | Dec 31, 2022 | Sep 30, 2022 | Dec 31, 2022 | Sep 30, 2022 | ||||||||||||||||||||||
| 1Q23 | 4Q22 | 1Q23 | 4Q22 | |||||||||||||||||||||||
| Aerospace and Defense | Broadband | |||||||||||||||||||||||||
| Gross profit | $ | 4,108 | $ | 889 | Gross profit | $ | (1,049) | $ | 117 | |||||||||||||||||
| Gross margin | 19 | % | 4 | % | Gross margin | (32 | %) | 3 | % | |||||||||||||||||
| Stock-based compensation expense | 273 | 181 | Stock-based compensation expense | 114 | 167 | |||||||||||||||||||||
| Asset retirement obligation accretion | 39 | 57 | Asset retirement obligation accretion | 12 | 7 | |||||||||||||||||||||
| Amortization of intangible assets | 293 | 58 | Amortization of intangible assets | 33 | — | |||||||||||||||||||||
| Variable compensation accrual adjustment | — | (804) | Variable compensation accrual adjustment | — | (236) | |||||||||||||||||||||
| Non-GAAP gross profit | $ | 4,713 | $ | 381 | Non-GAAP gross profit | $ | (890) | $ | 55 | |||||||||||||||||
| Non-GAAP gross margin | 22 | % | 2 | % | Non-GAAP gross margin | (27 | %) | 1 | % | |||||||||||||||||
| R&D expense | $ | 4,349 | $ | 3,506 | R&D expense | $ | 1,002 | $ | 1,355 | |||||||||||||||||
| Stock-based compensation expense | (193) | (170) | Stock-based compensation expense | (79) | (47) | |||||||||||||||||||||
| Variable compensation accrual adjustment | — | 347 | Variable compensation accrual adjustment | — | 289 | |||||||||||||||||||||
| Non-GAAP R&D expense | $ | 4,156 | $ | 3,683 | Non-GAAP R&D expense | $ | 923 | $ | 1,597 | |||||||||||||||||
| Non-GAAP profit | $ | 557 | $ | (3,302) | Non-GAAP profit | $ | (1,813) | $ | (1,542) | |||||||||||||||||
Contact:
EMCORE Corporation
Tom Minichiello
(626) 293-3400
investor@emcore.com